<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03849079</url>
  </required_header>
  <id_info>
    <org_study_id>UF 7542</org_study_id>
    <nct_id>NCT03849079</nct_id>
  </id_info>
  <brief_title>Validation of the HYPONUT Product</brief_title>
  <official_title>Clinical Validation of the Inactivation Procedure for Peanut Major Allergens in the HYPONUT Product</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The HYPONUT product was previously validated in a laboratory setting (&quot;Procédé de préparation
      d'aliment hypoallergénique&quot;, n° FR1250977) on 2012. A international patent was then obtained
      on 2013. Through the present study, the investigators would like to prove that the
      hypoallergenicity of the product is sustained in a clinical setting. Patients allergic to
      peanuts currently undergo in vivo tests to confirm their allergy: skin prick tests, and oral
      food challenges. In vitro tests are also performed (i.e. IgE levels for peanut and peanut
      components). The follow-up of patients consists in regular yearly or semestral evaluations.
      During one of these evaluation, the investigators will skin tests patients with the hyponut
      product to verify if they are sensitized to this last one as well. When skin tests will be
      negative, the investigators will propose to patients to take some of the product to verify
      its tolerability as well.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 24, 2019</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skin Prick Tests evaluation</measure>
    <time_frame>day patient enrolled</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oral food challenge evaluation</measure>
    <time_frame>day patient enrolled</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Peanut Allergy</condition>
  <arm_group>
    <arm_group_label>Hyponut</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hyponut</intervention_name>
    <description>Prick tests with hyponut</description>
    <arm_group_label>Hyponut</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Patients aged more than 6

          -  Patients suffering from peanut allergy and followed in the Allergy Unit of the
             University Hospital of Montpellier (France)

        Exclusion criteria:

          -  Pregnancy, or patients breast-feeding

          -  Patients treated with drugs possibly altering the results of the tests (e.g.
             anti-histamines)

          -  Patients presenting with dermographism

          -  Patients not fluent in French
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pascal DEMOLY, PhD</last_name>
    <phone>(0)467336112</phone>
    <phone_ext>+33</phone_ext>
    <email>p-demoly@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Davide P CAIMMI, MD</last_name>
    <phone>(0)467336112</phone>
    <phone_ext>+33</phone_ext>
    <email>dp-caimmi@chu-montpellier.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Montpellier</city>
        <state>Hérault</state>
        <zip>34090</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie PICCINATO</last_name>
      <phone>(0)467336106</phone>
      <email>l-piccinato@chu-montpellier.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 19, 2019</study_first_submitted>
  <study_first_submitted_qc>February 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2019</study_first_posted>
  <last_update_submitted>March 30, 2020</last_update_submitted>
  <last_update_submitted_qc>March 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Peanut Allergy</keyword>
  <keyword>Skin Prick Test</keyword>
  <keyword>Oral Food Challenge</keyword>
  <keyword>Hyponut</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peanut Hypersensitivity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

